Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
8308488
Reference Type
Journal Article
Title
Chemotherapeutic efficacy of Solanum trilobatum along with paclitaxel in lung cancer bearing swiss albino mice
Author(s)
Venugopal, R; Senthilnathan, P; Magesh, V; Rajkapoor, B; Sakthisekaran, D
Year
2007
Publisher
Asian Network for Scientific Information
Volume
3
Issue
2
Page Numbers
119-126
Language
English
DOI
10.3923/ijcr.2007.119.126
Abstract
The present study was conducted to ascertain the chemotherapeutic efficacy of Solanum trilobatum when administered along with paclitaxel against experimental lung carcinogenesis. Healthy male Swiss albino mice (6-8 weeks old) were treated with Benzo (a) pyrene (50 mg kg-1 body weight) to induce lung cancer. Paclitaxel at a dose of 33 mg kg-1 body weight intraperitoneally and Solanum irilohatum 200 mg kg-1 body weight orally was administrated for four weeks to lung cancer bearing animals. The level of lipid peroxides (LPO) was fomd to be markedly increased in carcinogen-administered animals, in contrast the activities/levels of the antioxidant status both in lung and liver were decreased in carcinogen administered animals. Upon Solanum trilobatum along with Paclitaxel administration the above pathological changes were bring back to near normal. From these findings we have concluded that Solanum trilobatum when administered along with paclitaxel prevents LPO and protects antioxidant system strongly aganist Benzo(a)pyrene induced lung cancer. © 2007 Academic Journals.
Keywords
Antioxidants; Benzo(a)pyrene; LPO; Lung cancer; Paclitaxel; Solanum trilobanum
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity